CardioFlow with EDTA
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 40% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
2 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Supplement Facts — Evidence Check
20 mg
(100% DV)
✅ 1.4× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
Calcium
50 mg
(5% DV)
Malic Acid
500 mg
200 mg
📊 Market median: 500.0mg (497 products)
📚 132 studies (Tier A: 0, B: 40)
Parsley
50 mg
Other Ingredients
Hydroxypropyl Methylcellulose
Magnesium Stearate
Silica
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Women (not pregnant or lactating)
Product Information
📋 Directions for Use
Directions: Adults, take 2 capsules twice daily as a dietary supplement or as directed by your doctor.
⚠️ Warnings & Precautions
Not for use by pregnant or lactating women. Persons with kidney disorders, or those taking prescription blood thinners should not use this product unless directed to do so by their physician. Consult your doctor before use if you have a medical condition or if you are taking any medications.
Keep out of the reach of children.
Do not use if clear safety seal around bottle neck is broken or missing.
Warning: Use only as directed.
🧪 Formulation Notes
Contains 500 mg of Calcium Disodium EDTA (Ethylenediaminetetraacetic Acid) per serving.
Additional Information
Store at room temperature, in a dry place.
Product Details
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100